Table 5 Comorbidities and age crosstabulation
Comorbidities and age crosstabulation | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
0–10 | 10–20 | 21–30 | 31–40 | 41–50 | 51–60 | 61–70 | 71–80 | More than 80 | Total | sig | ||
Diabetes | Count | 4 | 8 | 28 | 108 | 255 | 453 | 730 | 610 | 534 | 2730 | 0.000 |
% within disease | 0.1% | 0.3% | 1.0% | 4.0% | 9.3% | 16.6% | 26.7% | 22.3% | 19.6% | 100.0% | ||
Cardiovascular disorders | Count | 1 | 2 | 12 | 54 | 69 | 168 | 296 | 236 | 193 | 1031 | |
% within disease | 0.1% | 0.2% | 1.2% | 5.2% | 6.7% | 16.3% | 28.7% | 22.9% | 18.7% | 100.0% | ||
Chronic neurological disorders | Count | 0 | 0 | 0 | 5 | 8 | 14 | 36 | 24 | 19 | 106 | |
% within disease | 0.0% | 0.0% | 0.0% | 4.7% | 7.5% | 13.2% | 34.0% | 22.6% | 17.9% | 100.0% | ||
Pulmonary disorders | Count | 0 | 0 | 4 | 14 | 29 | 61 | 101 | 100 | 70 | 379 | |
% within disease | 0.0% | 0.0% | 1.1% | 3.7% | 7.7% | 16.1% | 26.6% | 26.4% | 18.5% | 100.0% | ||
Kidney disorders | Count | 0 | 2 | 8 | 17 | 34 | 76 | 96 | 78 | 52 | 363 | |
% within disease | 0.0% | 0.6% | 2.2% | 4.7% | 9.4% | 20.9% | 26.4% | 21.5% | 14.3% | 100.0% | ||
Obesity | Count | 0 | 0 | 2 | 3 | 4 | 14 | 25 | 40 | 28 | 116 | |
% within disease2 | 0.0% | 0.0% | 1.7% | 2.6% | 3.4% | 12.1% | 21.6% | 34.5% | 24.1% | 100.0% | ||
Absence of disease | Count | 1 | 5 | 37 | 129 | 226 | 420 | 797 | 599 | 548 | 2762 | |
% within disease2 | 0.0% | 0.2% | 1.3% | 4.7% | 8.2% | 15.2% | 28.9% | 21.7% | 19.8% | 100.0% | ||
Hypertension | Count | 2 | 7 | 23 | 99 | 180 | 263 | 329 | 179 | 151 | 1233 | |
% within disease2 | 0.2% | 0.6% | 1.9% | 8.0% | 14.6% | 21.3% | 26.7% | 14.5% | 12.2% | 100.0% | ||
TSH/T4 | Count | 0 | 1 | 2 | 4 | 7 | 12 | 30 | 12 | 10 | 78 | |
% within disease2 | 0.0% | 1.3% | 2.6% | 5.1% | 9.0% | 15.4% | 38.5% | 15.4% | 12.8% | 100.0% | ||
Thrombocytopenia | Count | 0 | 0 | 0 | 2 | 5 | 17 | 20 | 11 | 7 | 62 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 3.2% | 8.1% | 27.4% | 32.3% | 17.7% | 11.3% | 100.0% | ||
Addiction | Count | 0 | 0 | 3 | 5 | 8 | 0 | 8 | 11 | 11 | 46 | |
% within disease2 | 0.0% | 0.0% | 6.5% | 10.9% | 17.4% | 0.0% | 17.4% | 23.9% | 23.9% | 100.0% | ||
TB | Count | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 0 | 0 | 8 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 25.0% | 75.0% | 0.0% | 0.0% | 100.0% | ||
Hematopoietic cancers | Count | 0 | 0 | 2 | 4 | 5 | 10 | 20 | 10 | 8 | 59 | |
% within disease2 | 0.0% | 0.0% | 3.4% | 6.8% | 8.5% | 16.9% | 33.9% | 16.9% | 13.6% | 100.0% | ||
Hepatitis C | Count | 0 | 0 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 8 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 37.5% | 62.5% | 0.0% | 0.0% | 0.0% | 100.0% | ||
Stroke | Count | 0 | 0 | 10 | 13 | 37 | 34 | 68 | 52 | 33 | 247 | |
% within disease2 | 0.0% | 0.0% | 4.0% | 5.3% | 15.0% | 13.8% | 27.5% | 21.1% | 13.4% | 100.0% | ||
Chronic Hepatitis | Count | 0 | 0 | 2 | 5 | 10 | 12 | 10 | 8 | 5 | 52 | |
% within disease2 | 0.0% | 0.0% | 3.8% | 9.6% | 19.2% | 23.1% | 19.2% | 15.4% | 9.6% | 100.0% | ||
Breast cancer | Count | 0 | 0 | 0 | 6 | 9 | 7 | 6 | 0 | 8 | 36 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 16.7% | 25.0% | 19.4% | 16.7% | 0.0% | 22.2% | 100.0% | ||
Bone marrow cancer | Count | 0 | 0 | 0 | 0 | 0 | 10 | 6 | 7 | 0 | 23 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 43.5% | 26.1% | 30.4% | 0.0% | 100.0% | ||
Gastric cancer | Count | 0 | 0 | 1 | 4 | 4 | 2 | 0 | 0 | 2 | 13 | |
% within disease2 | 0.0% | 0.0% | 7.7% | 30.8% | 30.8% | 15.4% | 0.0% | 0.0% | 15.4% | 100.0% | ||
Pulmonary cancer | Count | 0 | 0 | 0 | 0 | 3 | 9 | 10 | 10 | 1 | 33 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 9.1% | 27.3% | 30.3% | 30.3% | 3.0% | 100.0% | ||
Laryngeal cancer | Count | 0 | 0 | 2 | 2 | 4 | 0 | 0 | 0 | 2 | 10 | |
% within disease2 | 0.0% | 0.0% | 20.0% | 20.0% | 40.0% | 0.0% | 0.0% | 0.0% | 20.0% | 100.0% | ||
Esophageal cancer | Count | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 5 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 20.0% | 80.0% | 100.0% | ||
Colon cancer | Count | 0 | 0 | 0 | 0 | 0 | 4 | 9 | 3 | 0 | 16 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 25.0% | 56.3% | 18.8% | 0.0% | 100.0% | ||
Bowel cancer | Count | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 10 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 0.0% | 0.0% | 0.0% | 100.0% | ||
Uterine and ovarian cancer | Count | 0 | 0 | 0 | 1 | 3 | 2 | 0 | 0 | 0 | 6 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 16.7% | 50.0% | 33.3% | 0.0% | 0.0% | 0.0% | 100.0% | ||
Bladder cancer | Count | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 3 | 6 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 50.0% | 0.0% | 0.0% | 0.0% | 0.0% | 50.0% | 100.0% | ||
Lymphoma | Count | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 5 | 11 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 54.5% | 45.5% | 100.0% | ||
Pregnancy | Count | 0 | 0 | 0 | 3 | 6 | 7 | 11 | 6 | 3 | 36 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 8.3% | 16.7% | 19.4% | 30.6% | 16.7% | 8.3% | 100.0% | ||
Prostate cancer | Count | 0 | 0 | 0 | 0 | 4 | 4 | 9 | 7 | 3 | 27 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 14.8% | 14.8% | 33.3% | 25.9% | 11.1% | 100.0% | ||
HIV | Count | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 2 | 2 | 10 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 60.0% | 20.0% | 20.0% | 100.0% | ||
HCV | Count | 0 | 0 | 0 | 0 | 0 | 4 | 1 | 0 | 0 | 5 | |
% within disease | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 80.0% | 20.0% | 0.0% | 0.0% | 100.0% | ||
Lupus | Count | 0 | 0 | 0 | 2 | 3 | 0 | 0 | 0 | 3 | 8 | |
% within disease | 0.0% | 0.0% | 0.0% | 25.0% | 37.5% | 0.0% | 0.0% | 0.0% | 37.5% | 100.0% | ||
Hypothyroidism | Count | 0 | 0 | 0 | 1 | 3 | 5 | 11 | 8 | 6 | 34 | |
% within disease2 | 0.0% | 0.0% | 0.0% | 2.9% | 8.8% | 14.7% | 32.4% | 23.5% | 17.6% | 100.0% | ||
IHD | Count | 0 | 0 | 0 | 2 | 4 | 8 | 9 | 11 | 3 | 37 | |
% within disease | 0.0% | 0.0% | 0.0% | 5.4% | 10.8% | 21.6% | 24.3% | 29.7% | 8.1% | 100.0% | ||
Total | Count | 8 | 25 | 136 | 486 | 923 | 1633 | 2650 | 2031 | 1714 | 9606 | |
% within disease | 0.1% | 0.3% | 1.4% | 5.1% | 9.6% | 17.0% | 27.6% | 21.1% | 17.8% | 100.0% | ||